Tutorials › Adaptive Clinical Trial Design › Partitioning Patients Into Stagewise Cohorts

Seamless Phase 2/3 Designs · Tutorial 464 of 799

Partitioning Patients Into Stagewise Cohorts

Learn to assign each participant to a stage by a reproducible enrollment rule while tracking separately whether the stage-specific data cut contains a complete, available endpoint.

Advanced 10 min read

What You'll Learn

  • Define a phase-transition timestamp and assign participants to mutually exclusive enrollment cohorts.
  • Distinguish consent, randomization, treatment, follow-up, and data availability dates.
  • Track endpoint maturity and database-cut status without changing stage membership.
  • Apply boundary-time conventions to participants enrolled around the transition.
  • Diagnose ambiguous timestamps, incomplete follow-up, and outcome-dependent classification.
  • Compare enrollment-defined cohorts with alternatives based on observation or data availability.

Why Cohort Boundaries Need an Operational Rule

In a seamless phase 2/3 trial, the phase label attached to a participant can affect how the study team summarizes stage-specific information and documents which data were available at a transition. A calendar description such as “phase 2 patients were enrolled before the transition” is not sufficient on its own: it leaves open whether enrollment means consent, randomization, first dose, or some other event. It also says nothing about a participant whose assigned endpoint is observed only after the transition.

The core distinction is between which enrollment cohort a participant belongs to and which of that participant’s data are available at a particular cut. Define the cohort using an event and boundary rule that can be applied consistently to every participant. Record follow-up and data availability separately. An endpoint that crosses the transition does not, by itself, move a participant to a different cohort.

Definition: An enrollment-defined stagewise cohort is the set of participants assigned to a stage by a prespecified enrollment event and a prespecified transition boundary. In the usual randomized-trial convention here, the enrollment event is randomization. Stage membership is a cohort label; it is not a statement that all endpoints for that participant are already observed or complete.

Specify the Event, Boundary, and Data Cut

Let \(t_i\) be the timestamp at which participant \(i\) is randomized, and let \(\tau\) be the effective transition timestamp. Use a single documented time standard, such as UTC, and define the boundary explicitly. One simple convention assigns randomizations strictly before \(\tau\) to stage 1 and randomizations at or after \(\tau\) to stage 2:

$$ C_i = \begin{cases} 1, & t_i < \tau,\\ 2, & t_i \geq \tau. \end{cases} $$

This half-open boundary convention makes the cohorts disjoint and exhaustive for randomized participants: a timestamp cannot be both before and at-or-after \(\tau\). A protocol could specify a different convention, but it must settle the exact-boundary case before enrollment. If a trial uses a different event as the enrollment marker, it must say so and apply it consistently. In particular, signing consent before \(\tau\) does not make a participant stage 1 if the defined enrollment event is randomization and randomization occurs at or after \(\tau\).

A data cut is a separate timestamp \(d\) at which the study freezes or extracts specified data. For a fixed-horizon endpoint requiring \(L\) days of follow-up, the nominal endpoint window for participant \(i\) ends at \(t_i+L\). Whether the endpoint is complete at cut \(d\) depends on the endpoint’s ascertainment rules and the actual available records, not just on cohort membership. For example, reaching \(t_i+L\) may be necessary but not sufficient if records have not yet been validated.

$$ \text{stage membership } C_i \text{ is determined by } (t_i,\tau); \qquad \text{data status at cut } d \text{ is determined by the endpoint record and } d. $$

A practical data record therefore keeps at least the randomization timestamp, assigned stage, endpoint window, endpoint status at each relevant cut, and the date that status was established. “Not yet complete at the cut” should be distinguishable from “complete but missing,” “not collected,” or “not applicable.” The precise endpoint status categories depend on the endpoint and its prespecified ascertainment rules.

Worked Example: Applying an Exact Transition Boundary

Suppose the effective transition is May 1 at 00:00 UTC. The protocol assigns randomizations before that time to stage 1 and randomizations at or after it to stage 2. Five records show: A was randomized April 30 at 23:58; B was randomized May 1 at 00:00; C consented April 30 but was randomized May 1 at 00:03; D was randomized April 29; and E was randomized May 1 at 00:02.

Apply the rule to each randomization timestamp. A and D are stage 1 because their timestamps are less than May 1 at 00:00. B is stage 2 because equality belongs to the at-or-after group. C and E are also stage 2. Thus there are two stage 1 participants and three stage 2 participants.

C’s earlier consent date does not change the result: consent is not the specified enrollment event. B’s timestamp does not require judgment about which side of the transition “feels” appropriate; equality was settled by the boundary convention. The conclusion assumes that all timestamps use the same time zone and that the recorded randomization times are reliable.

Follow-Up Can Cross the Transition

For a participant randomized before \(\tau\), a fixed endpoint window may end after \(\tau\). The participant remains in the stage 1 enrollment cohort under the rule above. If the data cut occurs before the endpoint window is complete, the endpoint is not yet mature at that cut. If the endpoint is later observed, the record can be updated as available while retaining the original stage label.

This distinction matters for endpoints whose measurement requires a specified follow-up duration. It also matters for event-time outcomes: an event may occur after the transition, while a participant who has not yet had an event may still be under observation. The date of an outcome event, or the date on which its status becomes known, does not replace the randomization date as the cohort-defining event. The endpoint’s analysis and censoring rules must still be followed; cohort assignment alone does not determine how an endpoint is analyzed.

Worked Example: A Fixed Follow-Up Window Crossing the Transition

Suppose the transition occurs May 1 at 00:00 UTC and the primary endpoint requires 28 days after randomization. Participant F is randomized April 28 at 10:00. The endpoint window ends 28 days later, May 26 at 10:00. A data cut on May 20 occurs before that endpoint window ends.

Because April 28 at 10:00 is before the transition, F belongs to stage 1. At the May 20 cut, F’s 28-day endpoint is not yet complete under the stated fixed-window definition: May 20 is earlier than May 26 at 10:00. F should therefore be recorded as stage 1 with the endpoint not yet mature at that cut, rather than being reassigned to stage 2 or treated as a completed endpoint.

If a later cut is May 30, the full 28-day window has elapsed. If the required endpoint data have also been ascertained and validated by May 30, the endpoint can be recorded as complete and available at that later cut. F’s cohort label remains stage 1. This example assumes the endpoint is defined by that 28-day window and does not have a separate early-completion rule.

Why the Partition Works—and What It Does Not Claim

The set-based definition makes the basic partition property explicit. Let \(S_1=\{i:t_i<\tau\}\) and \(S_2=\{i:t_i\geq\tau\}\), for all randomized participants with valid timestamps. Every such \(t_i\) is either less than \(\tau\) or greater than or equal to \(\tau\), so each participant is in at least one set. No timestamp can satisfy both conditions, so no participant is in both sets.

$$ S_1 \cup S_2 = S,\qquad S_1 \cap S_2 = \varnothing, $$

where \(S\) is the set of randomized participants covered by the rule. A data cut can change which endpoint records are available, but it cannot change either inequality defining \(S_1\) and \(S_2\). This is the justification for maintaining a stable cohort label while updating endpoint-status fields over time.

The partition is an operational classification, not a claim that stages are statistically independent, that participants have completed follow-up, or that data from one stage can be used for a particular inferential purpose. Those questions require their own design and analysis rules. Here, the goal is to make the participant roster and the status of its data interpretable without conflating them.

Worked Example: Cohort Membership Versus Endpoint Availability

Suppose stage 1 ends at a transition on March 12, and the primary endpoint requires 28 days after randomization. The data cut is April 4. Participant G was randomized March 1 and has a validated endpoint record dated March 30. Participant H was randomized March 5 and has a validated endpoint record dated April 3. Participant J was randomized March 10, so the 28-day window ends April 7; no complete endpoint record is available by the April 4 cut.

All three randomizations occurred before March 12, so G, H, and J are stage 1 participants. G’s endpoint window ended March 29; the validated March 30 record is available by the cut. H’s window ended April 2; the validated April 3 record is also available by the cut. J’s window ends April 7, which is after April 4, so J’s endpoint is not yet mature at this cut.

The roster therefore contains three stage 1 participants, while two have complete, validated endpoints available at the cut and one has an endpoint window still in progress. This arithmetic assumes that “28 days” is calculated from the recorded randomization timestamp and that the stated validation dates are the relevant availability dates. It would be incorrect to remove J from the stage 1 roster merely because J’s endpoint is not yet available.

Operational Checks and Common Failure Modes

Before a transition, the protocol and data-management plan should identify the effective timestamp, the event used for cohort assignment, the boundary convention, and the data cut or cuts. At each cut, reconcile the participant roster against the randomization system and check that every record has one stage label. The endpoint-status fields should then be checked against the endpoint window and the cut date.

  • Ambiguous date fields. Consent, randomization, first dose, and first endpoint assessment can fall on different dates. Confirm which field defines enrollment; do not choose a convenient date after seeing the data.
  • Unresolved boundary timestamps. Local time zones, daylight-saving changes, rounded timestamps, or inconsistent system clocks can put records on the wrong side of \(\tau\). Use a documented time standard and investigate records whose recorded precision cannot resolve the boundary.
  • Outcome-dependent membership. Classifying a participant according to when an outcome becomes available can make the cohort depend on follow-up or outcome behavior. Keep cohort assignment based on the specified enrollment event; record availability separately.
  • Incomplete follow-up mislabeled as missing. A participant whose endpoint window has not ended at the cut is not automatically a participant with a missing completed endpoint. Distinguish “not yet mature” from the endpoint’s defined missing-data statuses.
  • Duplicate or repeated records. Reconcile participant identifiers and randomization records. If the protocol permits re-randomization or multiple randomization episodes, specify whether the classification unit is the participant or the episode rather than silently counting one person twice.

The main alternative is to define stages by observation period or by which database cut contains an outcome. These can be useful labels for describing when measurements were made or became available, but they answer different questions from “which enrollment cohort does this participant belong to?” A single participant can have an enrollment-stage label and later observations collected after the transition. A data-cut-based label can also change from one extraction to the next, making the participant roster unstable. For a stagewise enrollment cohort, the randomization-time rule is usually clearer; use additional variables to describe observation timing and data availability.

A common mistake is to reason, “The endpoint was observed after the transition, so this person is a stage 2 participant.” That conclusion confuses outcome timing with the cohort-defining event. Under an enrollment-defined rule, the correction is direct: use the randomization timestamp to assign the stage, then determine separately whether the endpoint was complete and available at the specified cut. The limitation is equally important: this classification rule does not resolve how incomplete data should be analyzed, nor does it establish whether cross-transition observations are eligible for a particular analysis.

Key takeaway: Freeze cohort membership using a prespecified enrollment event and exact transition boundary. At every data cut, update endpoint availability and maturity as separate facts. A participant’s follow-up may cross the phase transition without changing the participant’s enrollment-stage cohort.

Check Your Understanding

Answer each question using an enrollment event of randomization and the boundary rule “before \(\tau\) is stage 1; at or after \(\tau\) is stage 2.”

  1. The transition is August 10 at 00:00 UTC. A participant consents August 9 but is randomized August 10 at 00:00. Which cohort applies, and why?
  2. A stage 1 participant’s 14-day endpoint window ends two days after the transition. Does that participant become stage 2?
  3. At a data cut, a stage 1 participant’s endpoint window is complete, but the required record has not been validated. What should be recorded about cohort membership and endpoint availability?
  4. Why can a cohort defined by “the cut at which the endpoint first appears” be unstable across data extracts?

Solutions. (1) Stage 2: randomization is at the transition timestamp, and equality is assigned to the at-or-after group; the earlier consent date is not the defined event. (2) No. The participant remains stage 1 because randomization occurred before \(\tau\); the endpoint window’s ending date concerns follow-up, not cohort assignment. (3) Retain the stage 1 label and record that the endpoint window is complete but the endpoint record is not yet validated or available under the stated rules. Do not call it a validated endpoint merely because the window ended. (4) The endpoint may appear only after later validation or extraction, so the participant’s cut-based label could change between snapshots. An enrollment-defined label stays fixed while availability is tracked separately.

Clinical Biostats